SEARCH

SEARCH BY CITATION

References

  • Amara S. G. and Kuhar M. J. (1993) Neurotransmitter transporters: recent progress. Annu. Rev. Neurosci. 0, 7393.
  • Barmashenko G., Kockskämper J. and Glitsch H. G. (1999) Depolarization increases the apparent affinity of the Na+–K+ pump to cytoplasmic Na+ in isolated guinea-pig ventricular myocytes. J. Physiol. 3, 691698.
  • Chen N. and Justice J. B. Jr (1998) Cocaine acts as an apparent competitive inhibitor at the outward-facing conformation of the human norepinephrine transporter: kinetic analysis of inward and outward transport. J. Neurosci. 18, 1025710268.
  • Chen N. and Reith M. E. A. (2002) Structure–function relationships for biogenic amine neurotransmitter transporters. In: Neurotransmitter Transporter: Structure, Function, and Regulation (Reith, M. E. A., ed.), pp. 53109. Humana Press Inc, Totowa, NJ.
  • Chen N., Trowbridge C. G. and Justice J. B. Jr (1999) Cationic modulation of human dopamine transporter: dopamine uptake and inhibition of uptake. J. Pharmacol. Exp. Ther. 290, 940949.
  • Chen N., Vaughan R. A. and Reith M. E. A. (2001) The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site-directed mutagenesis. J. Neurochem. 77, 11161127.
  • Chen N., Sun L. and Reith M. E. A. (2002) Cationic interactions at the human dopamine transporter reveal binding conformations for dopamine distinguishable from those for the cocaine analog 2β-carbomethoxy-3β-(4-fluorophenyl) tropane. J. Neurochem. 81, 13831393.
  • Chen N., Rickey J. and Reith M. E. A. (2003) Na+ stimulates binding of dopamine to the dopamine transporter in cells but not cell-free preparations. J. Neurochem. 86, 678686.
  • Dall'Asta V., Gatti R., Orlandini G., Rossi P. A., Rotoli B. M., Sala R., Bussolati O. and Gazzola G. C. (1997) Membrane potential changes visualized in complete growth media through confocal scanning microscopy of bis-oxonal-loaded cells. Exp. Cell. Res. 231, 260268.
  • Daniels G. M. and Amara S. G. (1999) Regulation trafficking of the human dopamine transporter. J. Biol. Chem. 274, 3579435801.
  • Doebler J. A. (2000) Comparative effects of carboxylic ionophores on membrane potential and resistance of NG108-15 cells. Toxicol. In Vitro 14, 235234.
  • Ereciñska M., Dagani F., Nelson D., Deas J. and Silver I. A. (1991) Relationship between intracellular ions and energy metabolism: a study with monensin in synaptosomes, neurons, and C6 glioma cells. J. Neurosci. 11, 24102421.
  • Falkenburger B. H., Barstow K. L. and Mintz I. M. (2001) Dendrodendritic inhibition through reversal of dopamine transport. Science 293, 24652470.
  • Gether U. (2000) Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr. Rev. 21, 90113.
  • Giros B., Jaber M., Jones S. R., Wightman R. M. and Caron M. G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606612.
  • Grånäs C., Ferrer J., Loland C. J., Javitch J. A. and Gether U. (2003) N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization. J. Biol. Chem. 278, 49905000.
  • Gu H., Wall S. and Rudnick G. (1994) Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J. Biol. Chem. 269, 71247130.
  • Haber R. S., Pressley T. A., Loeb J. N. and Ismail-Beigi F. (1987) Ionic dependence of active Na-K transport: ‘clamping’ of cellular Na+ with monensin. Am. J. Physiol. 253, F26F33.
  • Hille B. (2001) Ionic Channels of Excitable Membranes, 3rd edn, pp. 365453. Sinauer, Sutherland, MA.
  • Khoshbouei H., Wang H., Lechleiter J. D., Javitch J. A. and Gailli A. (2003) Amphetamine-induced DA efflux: a voltage sensitive and intracellular Na+-dependent mechanism. J. Biol. Chem. 278, 1207012077.
  • Kiedrowski L. (1999) N-methyl-D-aspartate excitotoxicity: relationship among plasma membrane potential, Na+/Ca2+ exchange, mitochondrial Ca2+ overload, and cytoplasmic concentrations of Ca2+, H+, and K+. Mol. Pharmacol. 56, 619632.
  • Krueger B. K. (1990) Kinetics and block of dopamine uptake in synaptosomes from rat caudate nucleus. J. Neurochem. 55, 260267.
  • Läuger P. (1991) Electrogenic Ion Pumps. Sinauer, Sunderland, MA.
  • Levi G. and Raiteri M. (1993) Carrier-mediated release of neurotransmitters. Trends. Neurosci. 16, 415419.
  • Li L.-B. and Reith M. E. A. (1999) Modeling of the interaction of Na+ and K+ with the binding of dopamine and [3H]WIN35,428 to the human dopamine transporter. J. Neurochem. 72, 10951109.
  • Li L. B., Cui X. N. and Reith M. E. A. (2002) Is Na+ required for the binding of dopamine, ampheramine, tyramine, and octopamine to the human dopamine transporter? Naunyn-Schmiedeberg's Arch. Pharmacol. 365, 303311.
  • Lichtshtein D., Dunlop K., Kaback H. R. and Blume A. J. (1979) Mechanism of monensin induced hyperpolarization of neuroblastoma-glioma hybrid NG108-15. Proc. Natl Acad. Sci. USA 76, 25802584.
  • McElvain J. S. and Schenk J. (1992) A multisubstrate mechanism for uptake of striatal dopamine and its inhibition by cocaine. Biochem. Pharmacol. 42, 21892199.
  • Melikian H. E. and Buckley K. M. (1999) Membrane trafficking regulates the activity of the human dopamine transporter. J. Neurosci. 19, 76997710.
  • Minta A. and Tsien R. Y. (1989) Fluoresent indicators for cytosolic sodium. J. Biol. Chem. 264, 1944919457.
  • Or E., Goldshleger R. and Karlish S. J. D. (1996) An effect of voltage on binding of Na+ at the cytoplasmic surface of the Na+–K+ pump. J. Biol. Chem. 271, 24702477.
  • Pifl C. and Singer E. A. (1999) Ion dependence of carrier-mediated release in dopamine or norepinephrine transporter-transfected cells questions the hypothesis of facilitated exchange diffusion. Mol. Pharmacol. 56, 10471054.
  • Pifl C., Agneter E., Drobny H., Reither H. and Singer E. A. (1997) Induction by low Na+ or Cl of cocaine sensitive carrier-mediated efflux of amines from cells transfected with the cloned human dopamine transporters. Br. J. Pharmacol. 121, 205212.
  • Pristupa Z. B., McConkey F., Liu F., Man H. Y., Lee F. J. S., Wang Y. T. and Niznik H. B. (1998) Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter. Synapse 30, 7987.
  • Rochdi M., Delort A. M., Guyot J., Sancelme M., Gibot S., Gourcy J. G., Dauphin G., Gumila C., Vial H. and Jeminet G. (1996) Ionophore properties of monensin derivatives studied on human erythrocytes by 23Na+ and K+ and H+ potentiometry: relationship with antimicrobial and antimalarial activities. J. Med. Chem. 39, 588595.
  • Rudnick G. (2002) Mechanisms of biogenic amine. In: Neurotransmitter Transporter: Structure, Function, and Regulation (Reith, M. E. A., ed.), pp. 2552. Humana Press Inc, Totowa, NJ.
  • Sitte H. H., Hiptmair B., Zwach J., Pifl C., Singer E. A. and Scholze P. (2001) Quantitative analysis of inward and outward transport rates in cells stably expressing the cloned human serotonin transporter: inconsistencies with the hypothesis of facilitated exchange diffusion. Mol. Pharmacol. 59, 11291137.
  • Sonders M. S., Zhu S. J., Zahniser N. R., Kavanaugh M. P. and Amara S. G. (1997) Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J. Neurosci. 17, 960974.
  • Uhl G. R. and Lin Z. (2003) The top 20 dopamine transporter mutants: structure-function relationships and cocaine actions. Eur. J. Pharmacol. 479, 7182.
  • Wallace B. A. (1990) Gramicidin channels and pores. Annu. Rev. Biophysics Biophys. Chem. 19, 127157.
  • Zahniser N. R. and Doolen S. (2001) Chronic and acute regulation of Na+/Cl dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol. Ther. 92, 2155.